Cyclooxygenase 2 expression by endothelin-1-stimulated mouse resident peritoneal macrophages in vitro

European Journal of Pharmacology

Volumn 356, Issue 1, 1998, Pages 73-80

  Shimada, Keiji ^a   Yonetani, Yukio ^a   Kita, Taizo ^a   Suzumura, Akio ^a   Takayanagi, Tetsuya ^a   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Endothelin ET(A) receptor antagonist; Endothelin ET(B) receptor antagonist; Endothelin 1; Macrophage

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOOXYGENASE 2; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DEXAMETHASONE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; INDOMETHACIN; ISOENZYMES; MACROPHAGES, PERITONEAL; MICE; NITROBENZENES; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, ENDOTHELIN; SULFONAMIDES;

EID: 0032575584     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00495-6     Document Type: Article

References (26)

1. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
2. Evett G.E., Xie W., Chipman J.G., Robertson D.L., Simmons D.L. Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes. Arch. Biochem. Biophys. 306:1993;169-177.
3. Fischer, M., Bogousslavsky (Eds.), 1996. Topics in experimental stroke; inflammatory cell contributions. J., Current Review of Cerebrovascular disease, 2nd edn., Current Medicine, Philadelphia, pp. 180-187.
4. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
5. Fuxe K., Cintra A., Andbjer B., Goldstein M., Agnati L.F. Centrally administered endothelin-1 produces lesions in the brain of the male rat. Acta Physiol. Scand. 137:1989;155-156.
6. Hirata, K. (Ed.), 1994. Functional interactions between enndothelin and other vasoactive substances in Japanese. J. Clinical and Experimental Medicine, Vol. 170, No. 5. Ishiyaku Publisher, Tokyo, pp. 374-378.
7. Juzan M., Hostein I., Gualde N. Role of thymus-eicosanoids in the immune response. Prostaglandins Leukot. Essent. Fatty Acids. 46:1992;247-255.
8. Kita, T., Kubo, K., Hiramatsu, K., Sakaki, T., Yonetani, Y., Sato, S., Fujimoto, M., Nakashima, T., 1998. Profiles of an intarvenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model. Life Sci., in press.
9. Kobayashi M., Nishikibe M., Maruyama H., Yano M., Ikemoto F., Ide K., Itoh S., Sasaki T. Localization of alteration of immunoreactive endothelin-1 in canine basilar arteries following subarachnoid hemorrhage. Acta Histochem. Cytochem. 28:1995;129-136.
10. Langenbach R., Morham S.G., Tiano H.F., Loftin C.D., Ghanayem B.I., Chulada P.C., Mahler J.F., Lee C.A., Goulding E.H., Kluckman K.D., Kim H.S., Smithies O. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:1995;483-492.
11. Lu X., Xie W., Reed D., Bradshaw W.S., Simmons D.L. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chiken embryo fibroblast. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7961-7965.
12. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
13. Mihara S., Nakajima S., Matumura S., Kohnoike T., Fujimoto M. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 268:1994;1122-1128.
14. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanous N., Jenette J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:1995;473-482.
15. 2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide. Prostaglandins Leukot. Essent. Fatty Acids. 55:1996;451-457.
16. Nie X.J., Olsson Y. Endothelin peptides in brain diseases. Rev. Neurosci. 7:1996;177-186.
17. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclooxygenase-2 gene expression neurons contributes to ischemic brain damage. J. Neurosci. 17:1997;2746-2755.
18. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and nonocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367-1379.
19. Reddy S.T., Herschman H.R. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 269:1994;15473-15480.
20. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry pharmacology, and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
21. Tordjman C., Coge C., Andre N., Rique H., Spedding M., Bonnet J. Characterization of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX2. Biochem. Acta. 1256:1995;249-256.
22. Tsai A., Hsi L.C., Kulmacz R.J., Palmer G., Smith W.L. Characterization of the tyrosyl radicals in ovine prostaglandin H synthase-1 by isotope replacement and site-directed mutagenesis. J. Biol. Chem. 269:1994;5085-5091.
23. Yamaura I., Tani E., Maeda Y., Minami N., Shindo H. Endothelin-1 of canine basilar artery in vasospasm. J. Neurosurg. 76:1992;99-105.
24. B receptor aggregates in rat hippocampus CA1 subfields following transient forebrain ischemia. J. Neurochem. 63:1994;1042-1051.
25. B receptor in rat macrophages. Jpn. J. Pharmacol. 73:1997;194. Suppl. 1.
26. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.